Clin2
NCT01696734Possibly a fitRecruiting

Domperidone for difficult stomach and reflux problems

Digestive System DisorderDyspepsiaEsophagitisGastroesophageal Reflux DiseaseGastroparesisHeartburnNausea and Vomiting

Treatments studied

Part of Digestive system clinical trials.

This trial studies whether domperidone can help people whose stomach or reflux symptoms did not improve with usual treatments. It focuses on symptoms like slow stomach emptying, hard-to-control acid reflux, or severe indigestion.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
200 people
Ages
16 years and older
Study type
Interventional

Who can take part

  • You have a gastrointestinal (stomach/throat) problem and standard treatments have already failed
  • Your symptoms fit one of these: slow stomach emptying (gastroparesis), hard-to-treat reflux (GERD), or severe indigestion (dyspepsia)
  • Your doctor has completed an evaluation to rule out other causes of your symptoms
  • You agree to take the study medicine domperidone and sign the consent form
  • Your recent blood tests are in an acceptable range (blood counts, liver enzymes, kidney function, and electrolytes like potassium and magnesium)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04699591Recruiting
Domperidone for severe stomach movement problems

This trial looks at whether domperidone can help people ages 12–21 with symptoms from stomach not moving well when usual treatments haven’t worked. It’s designed for cases where other causes have been ruled out and patients are monitored for possible heart and hormone side effects.

Kansas City, Missouri
NCT07004439Not yet recruiting
A registry study on RefluxStop for GERD treatment

This study will track how well the RefluxStop device works and its safety for treating acid reflux in a general hospital setting. It aims to help people with long-term GERD who have not found relief from other treatments.

Friedrichshafen
NCT06560307Recruiting
Enhanced stimulation for gastroparesis relief

This trial tests a new way to program an implanted device (Enterra®) to better treat severe nausea and vomiting caused by gastroparesis. If you have frequent nausea and vomiting despite other treatments, this study might help find a better setting for your device.

Tampa, Florida
NCT06695962Not yet recruiting· Phase 3
Domperidone for better blood sugar control in type 1 diabetes

This trial tests if domperidone, a medicine that helps the stomach empty faster, can improve blood sugar levels in people with type 1 diabetes who have slow stomach emptying but few symptoms. If you have type 1 diabetes, use an insulin pump or multiple daily injections, and have a continuous glucose monitor (CGM), this study might be for you.

Amiens
NCT06830226Enrolling by invitation
Domperidone and preterm breast milk nutrients

This study looks at how domperidone, a medicine used to help increase breast milk supply, affects the nutritional content of breast milk from mothers of premature babies. By understanding this, doctors can better support your baby's growth.

Lisbon
NCT06841406Recruiting· Phase 4
Budesonide for chronic stomach discomfort after meals

This trial tests whether a medicine called budesonide can help people with a type of chronic stomach discomfort that gets worse after meals (functional dyspepsia). If you often feel full or bloated after eating and have had a normal stomach exam, this study may be a good fit for you.

Leuven

Hear when a new Dyspepsia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.